论文部分内容阅读
对34例中晚期肝癌患者采用了经导管肝动脉化疗栓塞术（TACE），术后2周，再联合应用超声引导下行经皮瘤内无水酒精注射术（PEI）的双介入方法的治疗。27例肿块有不同程度缩小，其中6例缩小≥5％，11例缩小25％～50％，10例缩小＜25％，总缩小率为79．4％，全组平均生存期为15．4个月，治疗后半年、且1年、2年生存率分别为85．3％、61．8％、42．2％。认为TACE联合应用PEI的双介入疗法是延长中晚期肝癌病人生命的一种积极有效的治疗措施。
A total of 34 patients with advanced hepatocellular carcinoma underwent transcatheter hepatic arterial chemoembolization (TACE). Two weeks after operation, combined with ultrasound-guided dual-injection percutaneous intracavernous ethanol injection (PEI) was used. Twenty-seven tumors were reduced to varying degrees, of which 6 were reduced by ≥5%, 11 were reduced by 25% to 50%, 10 were reduced by <25%, and the total reduction was 79.4%. The average survival time was 15.4. Months, six months after treatment, and 1-year and 2-year survival rates were 85.3%, 61.8%, and 42.2%, respectively. It is considered that TACE combined with PEI is a positive and effective treatment for prolonging the life of patients with advanced liver cancer.